MEMPHIS, Tenn.--(BUSINESS WIRE)--FedEx Corp. (NYSE: FDX) today reported the following consolidated results for the second quarter ended November 30 (adjusted measures exclude the items listed below): | Fiscal 2026 | Fiscal 2025 | | | | | --- | --- | --- | --- | --- | | As Reported | Adjusted | As Reported | Adjusted | | | (GAAP) | (non-GAAP) | (GAAP) | (non-GAAP) | | | Revenue | $23.5 billion | $23.5 billion | $22.0 billion | $22.0 billion | | Operating income | $1.38 billion | $1.61 billion | $1.05 billion ...

Achieved record full year revenue of $1.39 billion, an increase of 13% year-over-year, driven by strong execution in Marketing & Distribution and significantly higher yields from owned Peruvian orchards in International Farming Generated nearly $180 million in cash flow from operations over the past two years; capital expenditures expected to step down to approximately $40 million in FY26 as Company enters phase of accelerated free cash flow generation Announced leadership succession plan in conjunction wit ...

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on Tuesday, January 13, 2026 at 9:45 a.m. Pacific Time. To access the live audio-only webcast, click here. The archived webcast will also be accessible on the Events & Presentations page in the Investors section of the Cr ...

FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D., Ph.D., to the Company’s Board of Directors. Dr. Bot is a biopharma executive with three decades of experience in research and development (R&D) with a focus on immune, cell, gene therapy and nanomedicines. He will serve as a member of the Science and Technolog ...

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere analytics, today announced the initiation of a new multiple myeloma (MM) Minimal Residual Disease (MRD) clinical trial in collaboration with the University of Athens. This retrospective study is a key component of Telo's expanding, multi-center MRD validation program and is designed to evaluate the clin ...

Not for distribution to United States Newswire Services or for dissemination in the United StatesVancouver, British Columbia – TheNewswire - December 18, 2025: GSP Resource Corp. (TSX-V: GSPR) (the “Company” or “GSP”) announces that it has closed a non-brokered private placement (the “Private Placement”), consisting of 2,000,000 flow-through shares (each, a “FT Share”) at a price of $0.12 per FT share for aggregate gross proceeds of $240,000. Each FT Share constitutes a “flow-through share” within the mean ...

ALEXANDRIA, Va. and CAMP HILL, Pa., Dec. 18, 2025 /PRNewswire/ -- Burke & Herbert Financial Services Corp. (the "Company" or "Burke & Herbert") (Nasdaq: BHRB) and LINKBANCORP, Inc. ("LINK") (Nasdaq: LNKB), the parent company of LINKBANK, today announced the signing of a definitive merger agreement pursuant to which Burke & Herbert will acquire LINK in an all-stock transaction valued at approximately $354.2 million or $9.38 per share of LINK common stock, based on a closing price for Burke & Herbert's common ...

NANO Nuclear Energy Inc. NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today reported its fiscal year 2025 financial results and provided a business update. Figure 1 - NANO N ...

Founder & CEO Steve Barnard to Transition to Executive Chairman of the Board; President and COO John Pawlowski to Become CEO at the close of the Annual Meeting of Shareholders in April 2026 Board Refreshment Initiative Underway –Three New Independent Directors Appointed in Advance of Expected Retirement of Current Board Chair at close of the Annual Meeting OXNARD, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, ...

Industry veteran to pass the reins to accomplished leader with proven track record for scaling digital B2C and B2B companies as part of company's CEO succession plan CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Cars.com Inc. (NYSE: CARS) (d/b/a "Cars Commerce Inc."), today announced that Tobias ("Tobi") Hartmann will become the company's next Chief Executive Officer (CEO) and be appointed to the Board of Directors, effective January 15, 2026. Hartmann succeeds Alex Vetter, who will step down as CEO and a member o ...